Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial
Titel:
Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial
Auteur:
Dorman, Klara Boeck, Stefan Caca, Karel Reichert, Maximilian Ettrich, Thomas J Oettle, Helmut Waidmann, Oliver Modest, Dominik P Müller, Lothar Michl, Patrick Kanzler, Stephan Pink, Daniel Reinacher-Schick, Anke Geißler, Michael Pelz, Henning Kunzmann, Volker Held, Swantje Schichtl, Thomas Heinemann, Volker Kullmann, Frank